154 related articles for article (PubMed ID: 1679277)
1. Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta.
Schluesener HJ; Meyermann R
Acta Neuropathol; 1991; 81(6):641-8. PubMed ID: 1679277
[TBL] [Abstract][Full Text] [Related]
2. Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2.
Schluesener HJ
J Neurosci Res; 1991 Feb; 28(2):310-4. PubMed ID: 2033654
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell lines.
Schluesener HJ
Autoimmunity; 1991; 9(3):269-75. PubMed ID: 1685677
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
6. The multidrug-resistance gene MDR1 is expressed in human glial tumors.
Becker I; Becker KF; Meyermann R; Höllt V
Acta Neuropathol; 1991; 82(6):516-9. PubMed ID: 1723831
[TBL] [Abstract][Full Text] [Related]
7. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
8. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
9. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells.
Abe T; Hasegawa S; Taniguchi K; Yokomizo A; Kuwano T; Ono M; Mori T; Hori S; Kohno K; Kuwano M
Int J Cancer; 1994 Sep; 58(6):860-4. PubMed ID: 7927879
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
[TBL] [Abstract][Full Text] [Related]
12. Murine P-glycoprotein on stromal vessels mediates multidrug resistance in intracerebral human glioma xenografts.
Takamiya Y; Abe Y; Tanaka Y; Tsugu A; Kazuno M; Oshika Y; Maruo K; Ohnishi Y; Sato O; Yamazaki H; Kijima H; Ueyama Y; Tamaoki N; Nakamura M
Br J Cancer; 1997; 76(4):445-50. PubMed ID: 9275020
[TBL] [Abstract][Full Text] [Related]
13. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K
Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
15. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
16. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
[TBL] [Abstract][Full Text] [Related]
18. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
[TBL] [Abstract][Full Text] [Related]
19. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines.
Herzog CE; Trepel JB; Mickley LA; Bates SE; Fojo AT
J Natl Cancer Inst; 1992 May; 84(9):711-6. PubMed ID: 1349044
[TBL] [Abstract][Full Text] [Related]
20. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
